User profiles for "author:Maria Jose Soler"

Maria José Soler Romeo

Hospital Vall d´Hebron
Verified email at vhebron.net
Cited by 10982

[HTML][HTML] Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology

D Batlle, MJ Soler, MA Sparks, S Hiremath… - Journal of the …, 2020 - journals.lww.com
The most common reported reasons for intensive care unit admission for patients with
severe coronavirus disease 2019 (COVID-19) are either hypoxemic respiratory failure …

[HTML][HTML] GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists

JL Górriz, MJ Soler, JF Navarro-González… - Journal of clinical …, 2020 - mdpi.com
Type 2 diabetes mellitus (T2DM) represents the main cause of chronic kidney disease
(CKD) and end-stage renal disease (ESKD), and diabetic kidney disease (DKD) is a major …

Coronavirus disease 2019 in chronic kidney disease

L D'Marco, MJ Puchades, M Romero-Parra… - Clinical kidney …, 2020 - academic.oup.com
The clinical spectrum of coronavirus disease 2019 (COVID-19) infection ranges from
asymptomatic infection to severe pneumonia with respiratory failure and even death. More …

Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes

M Ye, J Wysocki, J William, MJ Soler… - Journal of the …, 2006 - journals.lww.com
Abstract Angiotensin-converting enzyme 2 (ACE2) expression has been shown to be altered
in renal tubules from diabetic mice. This study examined the localization of ACE and ACE2 …

ACE and ACE2 activity in diabetic mice

J Wysocki, M Ye, MJ Soler, SB Gurley, HD Xiao… - Diabetes, 2006 - Am Diabetes Assoc
ACE-related carboxypeptidase (ACE2) may counterbalance the angiotensin (ANG) II–
promoting effects of ACE in tissues where both enzymes are found. Alterations in renal ACE …

[HTML][HTML] Characterization of ACE and ACE2 expression within different organs of the NOD mouse

H Roca-Ho, M Riera, V Palau, J Pascual… - International journal of …, 2017 - mdpi.com
Renin angiotensin system (RAS) is known to play a key role in several diseases such as
diabetes, and renal and cardiovascular pathologies. Its blockade has been demonstrated to …

[HTML][HTML] Acute kidney injury in patients treated with immune checkpoint inhibitors

S Gupta, SAP Short, ME Sise, JM Prosek… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitor-associated acute kidney injury (ICPi-AKI) has
emerged as an important toxicity among patients with cancer. Methods We collected data on …

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan

MJ Soler, M Ye, J Wysocki, J William… - American Journal …, 2009 - journals.physiology.org
Angiotensin-converting enzyme (ACE) 2 is a carboxypeptidase that degrades angiotensin II
and other peptides. In the kidney, ACE2 localization within the glomerulus and tubules is cell …

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

L Anguiano, M Riera, J Pascual… - Nephrology Dialysis …, 2015 - academic.oup.com
Background Patients with cardiovascular (CV) disease have an increased circulating
angiotensin-converting enzyme 2 (ACE2) activity, but there is little information about …

Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study

B Quiroga, MJ Soler, A Ortiz… - Nephrology Dialysis …, 2022 - academic.oup.com
Background Chronic kidney disease (CKD) patients are at high-risk for severe coronavirus
disease 2019 (COVID-19). The multicentric, observational and prospective SENCOVAC …